Cancer :: Researchers analyze new kinds of cancer-fighting antibodies
Two researchers from the University Hospital and the Center for Applied Medical Research (CIMA) from the University of Navarra have published an article in Nature Cancer Reviews.
Pharmaceutical
Heart Disease :: American Journal of Lifestyle Medicine investigates strategies for controlling heart disease
An estimated 75% of Americans seek medical advice from their doctors each year, confirming that health care workers wield significant influence over their patients? lifestyle choices. Unfortunately, physicians tend to underestimate their role as health counselors and don?t always suggest controlling heart disease risk factors, such as smoking, high cholesterol and blood pressure, obesity, and inactivity.
Anxiety :: Teva announces approval of Alprazolam ER Tablets
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) for Alprazolam Extended Release Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. Shipment of this product will begin immediately.
Pediatrics :: Most children in US hospitals receive medicines off-label
Nearly four out of five hospitalized children receive medications that have been tested and approved only for adults, according to a study of hundreds of thousands of patient records. This so-called “off-label” use of drugs was thought to be especially common in children, and the new research, the largest-ever U.S. pediatric study, confirms this.
Kidney Disease :: Triptolide – A potential drug for polycystic kidney disease
A treatment for polycystic kidney disease (PKD), a leading cause of fatal kidney failure worldwide, has been identified by a research team led by Yale biochemist Craig Crews, according to a report in the Proceedings of the National Academy of Sciences.
Gene :: Genetic analyis for personalizing of treatment of lung and colon cancer, certain sarcomas
Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity.
Fungal Infections :: New way to treat devastating fungal infections
Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
Chinese Medicine :: Health products and proprietary Chinese medicines found to be hazardous
The Hong Kong Department of Health (DH) urged members of the public not to buy or use four brands of health products and two brands of proprietary Chinese medicines after finding them to have contained potentially hazardous ingredients that may cause side effects.
Kidney Cancer :: A new pharmaceutical drug that halts progress of metastatic kidney cancer
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. The work was published recently in the prestigious international medical journal, the New England Journal of Medicine.
Dispensing :: Electronic Prescribing and Dispensing of Medicines
Electronic prescribing and dispensing of medicines is a key initiative of the Australian Government aimed at improving the delivery and quality of health care and achieve better health outcomes.